Prediction of overall survival or progression free survival by disease control rate at week 8 is independent of ethnicity: Western versus Chinese patients with first-line non-small cell lung cancer treated with chemotherapy with or without bevacizumab. [electronic resource]
Producer: 20141006Description: 253-7 p. digitalISSN:- 1552-4604
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Bevacizumab
- Carboplatin -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- blood
- Disease-Free Survival
- Humans
- Lung Neoplasms -- blood
- Models, Biological
- Paclitaxel -- administration & dosage
- Racial Groups
- Serum Albumin -- analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.